title: Current indications for ACE inhibitors and HOPE for the future.
abstract: Angiotensin-converting enzyme (ACE) inhibitors are effective in several disease states such as congestive heart failure, myocardial infarction, and diabetes. This article reviews the evidence supporting the clinical use, efficacy, and cost effectiveness of ACE inhibitors in these various disease states. With the findings of the Heart Outcomes Prevention Evaluation trial, these agents may now have a positive impact on the primary prevention of coronary artery disease. New and ongoing trials will provide more information about the role of ACE inhibitors in coronary artery disease.
authors.affiliation: Heartland Health, St Joseph, MO 65406-3398, USA. stephanie.burch@mail.heartland-health.com
authors.forename: Stephanie
authors.initials: S
authors.lastname: Burch
authors.forename: Narith
authors.initials: N
authors.lastname: Ou
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D000075202:Contraindications; D003928:Diabetic Nephropathies / Q000517:prevention & control; D017850:Economics, Pharmaceutical; D004496:Education, Continuing; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D014481:United States
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors